CDC published the 2017 US recommended immunization schedules for 0 through 18 years
On Feb. 10, 2017, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Children…
CDC published the 2017 U.S. recommended adult immunization schedule
On Feb. 10, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published the 2017 U.S. recommended…
FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
Artificial Intelligence | Biotechnology | Disease | Genomics | Infectious Disease | Medicine | Non-Profit Research | Therapeutics
Washington University invested $25 million in imaging sciences
On Nov. 18, 2016, Washington University in St. Louis launched a bold, $25 million initiative over the next…
Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
CDC published 2016-17 influenza vaccination recommendations
On Aug. 26, 2016, the U.S. Centers for Disease Control and Prevention (CDC) published 2016-17 influenza vaccination recommendations….
Biotechnology | Genomics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Veterinary
Southwest National Primate Research Center at Texas Biomed received $40 million NIH grant
On Aug. 4, 2016, the Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed)…
ACIP voted that live attenuated influenza vaccine (LAIV) should not be used during the 2016-2017 flu season
On Jun. 22, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
Agriculture | Biotechnology | Infectious Disease | Medicine | Pharmaceutical | Therapeutics | Vaccine
Texas A&M and iBio execute development agreement for plant-produced pharmaceuticals
On Jun. 7, 2016, IBio and the Texas A&M Institute of Infectious Animal Diseases (TAMUS) announced they had…
TEC Edmonton broke ground on newest technology accelerator with Merck Canada
On Sept. 5, 2017, business incubator TEC Edmonton announced a strategic partnership with Merck Canada to provide new…
Biotechnology | Diagnostics | Disease | Infectious Disease | Medicine | Non-Profit Research | Therapeutics
Texas A&M announced $150 million research campus
On May 2, 2016, John Sharp, Chancellor of The Texas A&M University System, unveiled plans to invest $150…
FDA approved Hiberix for full Hib vaccineﾠ series
On Apr. 29, 2016, GlaxoSmithKline Biologicals in Research Triangle Park, North Carolina, received U.S. Food and Drug Administration…
Antimicrobial Resistance Laboratory Network established by U.S. CDC
In 2016, the Centers for Disease Control and Prevention (CDC) announced the establishment of the Antimicrobial Resistance (AR)…
FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older
On Nov. 25, 2015, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved Fluad™ (Influenza…
The first ancient human genome from Africa was sequenced
On Oct. 8, 2015, a research team reported the first ancient human genome sequence from Africa. The genome…
Tu Youyou won a share of the Nobel Prize in Physiology or Medicine for her discoveries concerning a novel therapy against Malaria
On Oct. 5, 2015, Tu Youyou was awarded a half share of the Nobel Prize in Physiology or…
UNMC awarded $12 million grant by the Dept of HHS to establish and co-lead the nation’s National Ebola Training and Education Center
On Jul. 1, 2015, the UNMC/Nebraska Medicine, in collaboration with Emory University in Atlanta and Bellevue Hospital Center…
Zika virus circulation was confirmed in Brazil
On May 15, 2015, Zika virus circulation was confirmed in Brazil, and the Centers for Disease Control and…
Biotechnology | Infectious Disease | Measles | Polio | Vaccine | WHO | Women's Health
Pan American Health Organization declared Rubella Eliminated in the Americas
On Apr. 29, 2015, the Pan American Health Organization ﾠdeclared that the Americas region has become the first…
CDC published ACIP recommendations for typhoid vaccination
On Mar. 27, 2015, the U.S. Centers for Disease Control and Prevention (CDC) published new Immunization Practices Advisory…
The Human Vaccines Project was launched
On Feb. 17, 2015, the International AIDS Vaccine Initiative (IAVI) announced it had received a grant of US…
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
CDC’s Health Alert Network issued health advisory about multi-state outbreak of measles linked to Disneyland
On Jan. 23, 2015, the U.S. Centers for Disease Control and Prevention (CDC) Health Alert Network issued a…
Biotechnology | CDC | Diagnostics | Infectious Disease | Medicine | NIH | Therapeutics | Vaccine | WHO
The CDC responded to the West Africa Ebola outbreak
On Feb. 27, 2015, the U.S. Centers for Disease Control and Prevention (CDC) responded to the West Africa…
Alaskapox virus was first identified in a patient in Fairbanks
In 2015, the state of Alaska Department of Health announced they had identified Alaskapox virus in a patient…
BioCryst’s RAPIVAB(TM) (peramivir injection) received FDA approval for treatment of influenza in adults
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
Whole-genome sequences of 16 different mosquito species published in Science
On Nov. 27, 2014, two papers were published in Science that announced the completion and preliminary analyses of…
Philanthropist Paul G Allen donated $100 million to fight Ebola
On Oct. 23, 2014, philanthropist Paul G. Allen donated $100 million to fight Ebola and called on the…
OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvants
On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…
Biotechnology | CDC | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
The Centers for Disease Control and Prevention confirmed the first Ebola case in Dallas, Texas
On Sept. 30, 2014, the Centers for Disease Control and Prevention confirmed that Eric Duncan, a Liberian national…